Simple Therapies Boost Heart Attack Survival

Mukherjee believes the Swedish research could yield similar results in the U.S.
According to research recently published in the Journal of the American Medical Association and an accompanying commentary by Debabrata Mukherjee, M.D., chief of cardiovascular medicine at the Paul L. Foster School of Medicine, the increased use of evidence-based treatments for heart attacks like rapid angioplasty has led to a decrease in deaths from heart attacks.
Cardiovascular disease remains the most common cause of morbidity and mortality in the U.S.
In the study, Thomas Jernberg of the Karolinska Institute in Stockholm and his colleagues used data from a Swedish registry on more than 61,000 patients who experienced a deadly heart attack known as STEMI between 1996 and 2007.
“The combined use of simple therapies such as aspirin and cholesterol-lowering medications and balloon stents were associated with a significant reduction in mortality,” Mukherjee said. “We would expect to have similar findings in the United States.”
Read the full story from Reuters >>
Related
PAP Smears: What, Why and When
Related Stories
Willed Body Memorial Service Honors Those Who Donated
On Memorial Day each May, a service is conducted at the Texas Tech University Health Sciences Center Institute of Anatomical Sciences to pay respect to the Willed Body Program donors and their families.
Molecular Pathology Preceptorship: Unmatched Value and Experience
Ericka Hendrix, PhD, MB(ASCP)CM, Program Director and Associate Professor in the Master of Science in Molecular Pathology program in the School of Health Professions spoke about the program’s preceptorship.
Moseley Named Permian Basin Regional Dean of the Texas Tech University Health Sciences Center School of Nursing
Kelly Moseley, DHSc, R.N., has been named the TTUHSC School of Nursing regional dean in the Permian Basin.
Recent Stories
TTUHSC Teams Selected for 2025 Innosphere Life Sciences Accelerator Cohort
A pair of teams representing TTUHSC earned a spot among the 33 startup groups selected for the 2025 cohort of the Innosphere Life Sciences Accelerator.
Exploring New Frontiers in Patient Care
Jenna Kesey, Ph.D., associate managing director for the Clinical Research Institute (CRI) at TTUHSC, said it's important that the university provides opportunities for its patients to have access to innovative therapies through the clinical trial process.
Willed Body Memorial Service Honors Those Who Donated
On Memorial Day each May, a service is conducted at the Texas Tech University Health Sciences Center Institute of Anatomical Sciences to pay respect to the Willed Body Program donors and their families.